Evidence map›Paper›PMID 24285839›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Cutting edge: Expression of FcγRIIB tempers memory CD8 T cell function in vivo.

Gabriel R Starbeck-Miller, Vladimir P Badovinac, Daniel L Barber, John T Harty

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Article
  3. FcγRIIB functions as an IgG transporter in the mammary gland.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. FcγRIIIa is a noncanonical costimulatory molecule for CD8 T cells.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Article
  8. The emerging role of Fusobacteria in carcinogenesis.European journal of clinical investigation · 2024
    Review
  9. Review
  10. Article
  11. CD8Nature communications · 2024
    Article
  12. Review
  13. Article
  14. C-reactive protein impairs immune response of CD8Journal for immunotherapy of cancer · 2023
    Article
  15. FcγRIIB expressed on CD8Science translational medicine · 2023
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Gabriel R Starbeck-MillerInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA 52242;
Vladimir P Badovinac
Daniel L Barber
John T Harty
University of Iowa · USNational Institutes of Health · US

Funding

Immune Regulation in Mycobacterial InfectionsZIAAI001171 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BARBER, DANIEL · 2012 to 2025
$16.7M
TRAINING IN MECHANISMS OF PARASITISMT32AI007511 · NIAID · UNIVERSITY OF IOWA · PI BUTLER, NOAH SULLIVAN, WEBER, MARY · 1996 to 2025
$8.1M
PREDOCTORAL TRAINING PROGRAM IN IMMUNOLOGYT32AI007485 · NIAID · UNIVERSITY OF IOWA · PI Kevin L Legge · 1995 to 2026
$5.4M
Regulation of primary and secondary CD4 and CD8 T cell memoryR37AI042767 · NIAID · UNIVERSITY OF IOWA · PI HARTY, JOHN T · 2008 to 2017
$4.7M
TRAINING IN IMMUNOLOGY AND MOLECULAR PATHOGENESIST32AI007610 · NIAID · EMORY UNIVERSITY · PI EVAVOLD, BRIAN D · 2000 to 2014
$4.4M
Memory CD8 T cell immunity to Plasmodium liver stage infecR01AI085515 · NIAID · UNIVERSITY OF IOWA · PI HARTY, JOHN T · 2010 to 2020
$4.1M
T cell immunity to Plasmodium sporozoite immunizationR01AI095178 · NIAID · UNIVERSITY OF IOWA · PI HARTY, JOHN T · 2012 to 2016
$2.6M
Memory CD8 T Cell Responses After Multiple Antigen EncountersR01AI083286 · NIAID · UNIVERSITY OF IOWA · PI BADOVINAC, VLADIMIR P · 2009 to 2012
$1.5M
Cellular intermediates in stable memory CD8 T cell maintenanceR21AI096850 · NIAID · UNIVERSITY OF IOWA · PI BADOVINAC, VLADIMIR P, HARTY, JOHN T · 2012 to 2013
$414k
NIAID NIH HHS AI083286NIAID NIH HHS AI096850NIAID NIH HHS AI42676NIAID NIH HHS AI85515NIAID NIH HHS AI90850NIAID NIH HHS AI95178NIAID NIH HHS AI96850NIAID NIH HHS R01 AI083286NIAID NIH HHS R01 AI085515NIAID NIH HHS R01 AI095178NIAID NIH HHS R21 AI096850NIAID NIH HHS R37 AI042767NIAID NIH HHS T32 AI 007511NIAID NIH HHS T32 AI007511NIAID NIH HHS T32 AI007610
6 · The paper itself

Abstract

During reinfection, high-affinity IgG Abs form complexes with both soluble Ag and Ag displayed on the surface of infected cells. These interactions regulate cellular activation of both innate cells and B cells, which express specific combinations of activating FcγRs (FcγRI, FcγRIII, FcγRIV) and/or the inhibitory FcγR (FcγRIIB). Direct proof for functional expression of FcγR by Ag-specific CD8 T cells is lacking. In this article, we show that the majority of memory CD8 T cells generated by bacterial or viral infection express only FcγRIIB, and that FcγRIIB could be detected on previously activated human CD8 T cells. Of note, FcγR stimulation during in vivo Ag challenge not only inhibited the cytotoxicity of memory CD8 T cells against peptide-loaded or virus-infected targets, but FcγRIIB blockade during homologous virus challenge enhanced the secondary CD8 T cell response. Thus, memory CD8 T cells intrinsically express a functional FcγRIIB, permitting Ag-Ab complexes to regulate secondary CD8 T cell responses.

Indexed as

Gene Expression RegulationAnimalsAntigensCD8-Positive T-LymphocytesCell LineCytotoxicity, ImmunologicEpitopes, T-LymphocyteHumansImmunologic MemoryLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMiceMice, KnockoutReceptors, IgGAntigensEpitopes, T-LymphocyteReceptors, IgG

Identifiers

PMID24285839
PMCPMC3874719
OpenAlexW1960158273

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.